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ABSTRACT
Objective: To compare ‘cytokines’ and ‘bone turnover markers’ in pre- and post-menopausal women and identify their relation-
ship with bone mineral density (BMD) in both groups. 
Study Design: A cross-sectional study.
Place and Duration of Study: Department of Biological & Biomedical Sciences, The Aga Khan University, Karachi, Pakistan,
from June 2017 to August 2019.
Methodology:  Groups  comprised  of  healthy  premenopausal  and  postmenopausal  women  from  the  general  population
belonging to different ethnic groups and socio-economic status. Serum cytokines and bone turnover markers were assessed by
solid-phase immunoassays, BMD (gm /cm2)] measurement was performed by dual-energy X-ray absorptiometry at the hip,
lumbar spine, and proximal femur. Results were interpreted as a sum of T scores calculated by BMD of the above-mentioned
sites.
Results: Cytokines and bone turnover markers were significantly high in post-menopausal women (p<0.001). A negative corre-
lation (r = 0.32) of TNF α with BMD (total T scores) observed in premenopausal women was found to be significant, however, no
significant association of BMD was detected in post-menopausal women.
Conclusion: There is an increase in the production of cytokines and bone turnover markers after menopause. TNF-α follows
this usual pattern of increase in post-menopausal women and can predict impending bone loss and osteopenia in premeno-
pausal females. Therefore, estimation of this cytokine in pre-menopausal women can give a fair indication of a decline in BMD,
bone health, and risk of future osteoporosis.
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INTRODUCTION
Osteoporosis is the most common silent disease with the third-
highest incidence in the aging population.1 The important public
health problem has added an increased incidence of fractures,
disabilities, deprived quality of life with increased mortality in
the aging population of developing countries.1-3
Bone turnover is the process of bone resorption followed by
replacement by new bone formation. Osteoclast and osteoblast
are the main cells involved in this process. Osteoclasts cause
bone resorption; whereas, osteoblasts take part in the forma-
tion of new bone.4
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One  of  the  mechanisms  responsible  for  communication  is
through cytokines. Cytokines are small proteins that facilitate
interactions between cells; cytokines like interleukin-1, M-CSF,
tumor necrosis factor; and interleukin-6 can incite the formation
as well as bone-resorbing capability of osteoclasts. Meanwhile,
cytokines such as interleukin-4, gamma-interferon, and trans-
forming factor-beta inhibit both osteoclast formation and osteo-
clast  activity.Therefore,  specific  cytokine  levels  in  the  bone
marrow microenvironment may play a crucial role in the regula-
tion of osteoclast activity and knowledge of these cytokines can
provide insight into normal calcium homeostasis and disorders of
bone turnover, such as osteoporosis.5 Clinically, osteoporosis is
diagnosed by using dual energy x-ray absorptiometry (DXA) in
post-menopausal women. BMD; T-score of - 2.5 or less at any
observed site or history of a former fragility fracture is considered
for osteoporosis.6 The loss of bone, which occurs as a result of an
imbalance between the bone foundation and resorption, can be
measured by BMD as well as by changes in biochemical markers
like osteocalcin, C-terminal telopeptide for identification of osteo-
porotic fractures.7  DXA scan however has its  limitations as a
costly investigation which is not available in all hospitals.
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Estrogen regulates the production and activity of pro-inflamma-
tory  cytokines  like  ‘interleukin  (1L)-1’,  ‘IL-6’  and  ‘tumor
necrosis  factor-alpha  (TNF-  α).  Its  deficiency  in  postmeno-
pausal  women  leads  to  the  increased  production  of  these
cytokines which activate the genesis of osteoclasts, leading to
bone loss.8 TNF-α along with other pro-inflammatory cytokines
takes part in bone remodelling, maintenance of bone homeos-
tasis by initiating osteoclastogenesis and restraining delinea-
tion of osteoblast.9 Osteoclast formation is regulated by TNF α
through ‘receptor activator of nuclear factor-kappa-Β ligand
(RANKL)’,  which  is  well  known  for  its  role  in  normal  bone
modeling  and  remodeling.  IL-6  expedites  the  activity  of
osteoblasts as well  as osteoclasts.  Both TNF-α and IL-6 are
responsible for immune-mediated bone diseases of which post-
menopausal osteoporosis and rheumatoid arthritis are worth
mentioning.10
Markers of bone metabolism are innovative tools that perceive
the process of bone remodelling concerning its configuration
and resorption. The wider accessibility of dependable, econom-
ical, and specific assays for bone turnover would supplement
the BMD measurement in the detection,  management,  and
follow-up  of  osteoporosis.  Therefore,  keeping  in  mind,  the
growing  prevalence  of  osteoporosis  and  its  impact  on  the
health and economy of Pakistan. It was therefore, hypothe-
sised  that  loss  of  minerals  in  bones  can  be  detected  by
increased  levels  of  proinflammatory  cytokines  and  bone
turnover markers.
 The objective of this study was to explore the association of
cytokines and bone turnover markers with the probable risk of
osteoporosis by comparison of these markers in pre- and post--
menopausal  women  and  identify  the  relationship  of  these
biomarkers with bone mineral density (BMD).
METHODOLOGY
This cross-sectional study was conducted from June 2017 to
August 2019 at the Department of Biological and Biomedical
Sciences,  The  Aga  Khan  University,  Karachi,  Pakistan,
according  to  Helsinki  Declaration  next  to  endorsement  by
‘Ethical Review Committee of The Aga Khan University 4146-
BBS-ERC-16’. Sample size calculation was calculated by ‘Open
Epi sample size calculator’ with a 99% confidence interval and
5% margin of error. 
The sample size was estimated to be 162.11 Pre- and post-meno-
pausal women with the age ranging from 20 to 70 years were
selected from the outdoor patient clinic of The Aga Khan Univer-
sity and the community. Healthy female subjects; post-meno-
pausal women; 5 years of menopause or greater and premeno-
pausal women with regular cycles (20-45 years of age) of all
ethnic groups and socioeconomic status were included. Women
with  ‘metabolic  diseases,  hyperthyroidism,  hyperparathy-
roidism, Diabetes mellitus,  autoimmune diseases,  history of
premature  menopause  (<40  years),  cirrhosis,  hepatitis  and
hepatoma’  were  excluded  from  the  study.   Women  with  a
history of intake of drugs like bisphosphonates, calcitonin, anti-
convulsants, glucocorticoids, vitamin D, calcium and hormonal
replacement  therapy,  history  of  a  previous  fracture,  and
smokers were also excluded. 
After taking informed consent, history, and physical examina-
tion, blood samples were collected. Bone density measured as
g/cm2 was converted into reference values for age as T scores.
Details of Kits: Serum interleukin 6 was determined by using a
commercially available Kit Cat # BMS213-2by Bioassay Tech-
nology Laboratory. The sensitivity of the assay was 0.03 pg/m-
L. Serum Tumor necrosis factor Alpha (TNF-α) was analyzed by
“Enzyme immunoassay Kit Cat No E 0082Hu” by Bioassay Tech-
nology Laboratory. The sensitivity of the assay was 1.52ng/L.
Osteocalcin was measured by “EIA kit Catalogue no EI555Hu by
Bioassay Technology Laboratory.  Assay sensitivity was 0.026
ng/ml.  serum human cross-linked carboxy-terminal  telopep-
tides type I collagen was done by using Kit-Cat No. E6465Hu
(Bioassay Technology Laboratory). The sensitivity of the assay
was 0.17ng/ml. The biomarkers (serum cytokines, osteocalcin,
carboxytelopeptide, serum interleukin 6 (IL-6), serum TNF-α
was performed as per manufacturers protocol
Data was initially entered in Excel, imported to statistical soft-
ware  SPSS  version  19.0.  Quantitative  parameters  were
expressed  as  mean  ±  S.D.  The  quantitative  variables  were
compared based on the Student t-test.   Pearson correlation
coefficient was used (p-value of <0.05; statistically significant)
to determine the association of different study parameters.
RESULTS
Table I compares demographic, bone turnover markers, and
cytokines  in  pre-menopausal  (n=60)  and  post-menopausal
(102) female subjects. TNF α and IL- 6 was higher in post-meno-
pausal females 81.52 ± 13.87vs. 7.26 ± 1.36; p<0.001) and
10.64 ± 3.12 vs. 1.33 ± 0.24; p<0.001). The bone turnover
markers  Osteocalcin  and  Carboxytelopeptide  were  signifi-
cantly higher in the post-menopausal group (p<0.001).
Table II represents the correlation of DXA scores in premeno-
pausal and post-menopausal groups of subjects with study vari-
ables.  A significant negative correlation (r = 0.32) of BMD was
observed with TNF α in premenopausal women. When compared
with bone density measured at various sites (Table III), it was
observed that TNF-α correlated with BMD at the hip (r=0.372,
p<0.001) and femoral neck (r=-0.269, <0.05). Figure 1a and 1b
represent the correlation of TNF α with BMD scores in premeno-
pausal and postmenopausal females. The correlation of age with
BMD in both groups is represented in Figure 2a and 2b.
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Table I: Biophysical and biochemical variables in premenopausal and postmenopausal women.
 
Premenopausal Postmenopausal
p-valuewomen (n=60) women (n=102)
Mean ± S. D Mean ± S.D
Age (years) 32.63 ± 7.263 53.22 ± 5.616 p < 0.001
BMI kg/m2 23.2 ± 4.51 28.37 ± 4.91 p < 0.001
T scores -1.37±0.95 -1.47 ±0.97 0.524
Bone formation marker
Serum osteocalcin 10.21 ± 5.88 20.79 ± 11.73 p < 0.001
Serum carboxytelopeptide (CTX) 6.26 ± 4.47 30.71 ± 18.97 < 0.001
Serum Cytokines
Tumor necrosis factor alpha [(TNF-α) (pg/ml)] 7.26 ± 1.37 81.52 ± 13.87 < 0.001
Interleukin 6 [(IL-6) (pg/ml)] 1.33 ± 0.24 10.64 ± 3.12 < 0.001
Values are expressed as mean ± SD. Results compared by Independent Sample t-test. 
Table II: Correlation of T scores with proinflammatory cytokines and bone turnover markers in pre- and post-menopausal females.
Study variables Premenopausal females Postmenopausal females
Age (years) -.364(**) -.545(**)
BMI kg/m2 0.163 0.139
Tumor necrosis factor alpha (TNF-α) -.324(*) 0.006
Interleukin 6(IL-6) 0.069 -0.06
Osteocalcin 0.15 0.113
Carboxytelopeptide (CTX) -0.092 -0.03
Pearson correlation is significant at 0.05 (2-tailed). ** Correlation is significant at the.001 level (2-tailed).
Table III: Correlation of T scores at 3 sites with proinflammatory cytokines and bone turn over markers in pre and post-menopausal females.
Variables Hip Spine Femoral NeckPre Post Pre Post Pre Post
Tumor necrosis factor alpha (TNF-α) -.372(**) 0.005 -0.241 -0.011 -.269(*) 0.027
Interleukin 6 (IL-6) 0.064 -0.064 0.042 -0.025 0.084 -0.075
Osteocalcin 0.128 0.055 0.156 0.094 0.131 0.153
Carboxytelopeptide (CTX) -0.062 -0.034 -0.131 -0.079 -0.061 0.052
Correlation is significant at 0.05 (2-tailed).  Correlation is significant at the.001 level (2-tailed).
Figure 1a: Correlation of bone mineral density scores with TNF-α in
pre-menopausal females.
Figure 1b: Correlation of bone mineral density scores with TNF-α in
post-menopausal females.
Figure 2a: Correlation of bone mineral density scores with age in pre--
menopausal females.
 
Figure 2b: Correlation of bone mineral density scores with age in post-
menopausal females.
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DISCUSSION
Menopause is a phase of changeover in the female reproduc-
tive cycle that has an impact on bone health and mineral
metabolism.  As ovarian function declines with menopause,
there is a rise of pro-inflammatory cytokines leading to post--
menopausal  bone  loss  and  osteoporosis.  Postmenopausal
osteoporosis is a point of concern for clinicians as well as
epidemiologists due to its increased incidence and the forth-
coming burden on the health economy in low-middle-income
countries. The new emerging clinical and molecular evidence
suggests  a  link  of  inflammation  in  the  etiopathogenetic
mechanisms leading to osteoporotic fractures. The role of
pro-inflammatory  cytokines  in  the acceleration of  bone loss
has thus been documented in postmenopausal women.12 In
addition to that, the hormonal imbalance exerts physiolog-
ical  and  biochemical  changes,  which  increase  the  bone
turnover in these females which was manifested by reduced
BMD in our research results.
Specific  cytokine  levels  in  the  bone  homeostasis  play  a
crucial role in the regulation of osteoclast activity and there-
fore comprehension of these cytokines can provide insight
into  normal  calcium homeostasis  and  conditions  of  bone
turnover  like  osteoporosis.5  It  was  observed  high  TNF-α
levels in post-menopausal females which supports the fact
that TNF-α is an imperative mediator of bone resorption13
which increases osteoclast differentiation, inhibits osteoblast
survival and therefore leading to low  BMD.14 A  three years
study on the effect of TNF-α blocking therapy on bone forma-
tion and bone resorption documented an increase in bone
formation marker; bone-specific alkaline phosphatase (BALP)
which  causes  bone  mineralization  process  and  collagen
synthesis.15  In addition that bone resorption markers CTX
was reduced due to the blocking effect of TNF-α caused due
to a reduction in collagen degradation.15  The role of  Inflam-
mation in the revelation of osteoporosis by increased inter-
leukin levels in post-menopausal women was observed by an
increase in IL-6 in this study, which is comparable to a study
done by Jeedigunta et al.8 However, no relationship between
bone‐resorbing cytokines and ovarian function was observed
by other researchers.
The  high  TNF-α  and  IL-6  observed  in  post-menopausal
females regarding the role of IL-6 and TNF-α in bone resorp-
tion and formation processes are documented. In a study,
women  in  both  pre-  and  post-menopausal  groups  were
osteopenic16  and  a  significant  negative  co-relation  of  TNF-α
with  BMD  was  noticed  in  premenopausal  women.  It  is
expected  estrogen  deficiency  in  postmenopausal  women
and loss of  ovarian function indorses signaling and gene
expression  cascade  of  series  of  pro-inflammatory  cytokines
which stimulates macrophage colony-stimulating factor (M-
CSF) as well as  IL-6.17 Recent literature suggests that exoge-
nous  TNF-α  aggravates  endoplasmic  reticulum  stress,
decreases collagen secretion,  and prompts apoptosis  and
inflammatory  response  in  human  osteoblast-like  SaOs-2
cells. Improvement in bone formation and lumbar spine BMD
was  observed  with  anti-TNF-α  therapy.15  The  finding  high-
lights  the consideration of  the association of  TNF α with
osteopenia for risk assessment of future osteoporosis and
bone health.
Aging is also a contributing factor to increased levels of pro-
inflammatory cytokines and low BMD.18,19  Hence,  the authors
observed low BMD with advancing age. This observation is
supported by other studies done in elderly postmenopausal
women.18,20 Studies have suggested low BMI  responsible for
osteoporosis  and  accompanying  fractures.21,22  This  can  be
explained  by  the  fact  that  a  larger  body  mass  enforces
mechanical load on the bone which increases the bone mass
as compensation. A study was done on Qatari women never-
theless revealed greater BMD in an obese group with its posi-
tive association with BMD at spinal and femoral sites.23 It was
observed high BMI in post-menopausal females without any
significant association with BMD supported by literature.24
An increase in bone turnover irrespective of the cause leads to
weakening of bone microarchitecture; hence, contributing to
an increased risk of fracture which is independent of low BMD.
Osteocalcin  and  CTX  levels  were  high  in  post-menopausal
women in this study, which is supported by another study.17
This study highlights the role of cytokines especially TNF-α in
the perimenopausal stage as the probable link of inflammation
leading to osteopenia. An inclusive evaluation of inflammatory
biomarkers and related metabolite pathways can help in deter-
mining bone outcomes, predict subacute stage after fractures,
which  can  be  helpful  to  reduce  bone  loss,  maintain  bone
density, and diminish susceptibility of secondary fractures.
TNF-α  though  detected  as  a  biomarker  for  osteopenia  in
premenopausal  women; its  utility  in predicting osteoporosis
needs more research evidence and inclusion of osteoporotic
females with high T scores. The authors have also not taken
the  effect  of  other  hormones  which  impact  calcium  homeos-
tasis and bone turnover in our study. However, the strength of
the  study  is  a  suggestion  for  consideration  of  high  TNF-α
(detected due to any other cause) for evaluation of BMD, irre-
spective of the reproductive age of a woman.
CONCLUSION
There is an increase in the production of cytokines and bone
turnover markers after menopause. TNF-α though follows this
usual pattern of increase in post-menopausal women, yet can
predict  impending  bone  loss  and  osteopenia  in  premeno-
pausal females. Therefore, estimation of this cytokine in pre--
menopausal women can give a fair indication of a decline in
BMD, bone health, risk of future osteoporosis, and plan of
preventive measures to be taken before the onset of meno-
pause.
RECOMMENDATION:
The  authors  recommend  BMD  be  performed  in  case  an
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increase in TNF-α is detected due to other causes in male and
female subjects to identify the risk of osteoporosis.
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